Evaluation of Cognitive Status, Kinesiophobia, Physical Activity Level, and Functional Performance in Coronary Intensive Care

Heart Diseases Clinical Trial

Official title:

Evaluation of Cognitive Status, Kinesiophobia, Physical Activity Level, and Functional Performance in Coronary Intensive Care

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05553106
• Other study ID #: GO 20/299
• Status: Active, not recruiting
• Start date: September 23, 2022
• Est. completion date: November 2022

Study information

• Verified date: October 2022
• Source: Hacettepe University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The aim of our study is to evaluate cognitive status, kinesiophobia, physical activity level, and functional performance in coronary intensive care.

Description:

This study will be performed on patients who are hospitalized in the coronary intensive care unit, who can take simple commands, and whose condition is physiologically stable.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 10
• Est. completion date: November 2022
• Est. primary completion date: November 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Volunteering to participate in the research

• Being under surveillance in the coronary intensive care unit

Exclusion Criteria:

• Presence of neurological disease that may affect the cognitive status

• Not being clinically stable

• Not to cooperate

Related Conditions & MeSH terms

• Heart Diseases

Locations

Country	Name	City	State
Turkey	Hacettepe University	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Functional Performance Assessment	Functional status score for the intensive care unit (FSS-ICU) will be used.	2 weeks
Secondary	Symptom Assessment	Cardiac symptom survey will be used.	2 weeks
Secondary	Cognitive Status Assessment	The Montreal Cognitive Assessment (MoCA) will be used	2 weeks
Secondary	Physical Activity Level	Physical activity level will be evaluated using the International Physical Activity Questionnaire - Short Form (IPAQ-SF).	2 weeks
Secondary	Fear of Movement	Fear of movement will be evaluated using the Fear of Activity in Patients with Coronary Artery Disease (Fact-CAD).	2 weeks